Publications by authors named "Joos Lebesque"

Claim this Profile
M
Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.
Jothybasu Selvaraj, Joos Lebesque, Andrew Hope, Matthias Guckenberger, Maria Werner-Wasik

Radiother Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
Ruud C Wortel, Luca Incrocci, Floris J Pos, Uulke A van der Heide, Joos V Lebesque

Int J Radiat Oncol Biol Phys· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer.
Ruud C Wortel, Marnix G Witte, Uulke A van der Heide, Floris J Pos, Joos V Lebesque

Radiother Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on 'Multi-modality functional image guided dose escalation in the presence of uncertainties'.
Marnix G Witte, Joos V Lebesque, Marcel van Herk

Radiother Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
Ruud C Wortel, Luca Incrocci, Floris J Pos, Joos V Lebesque, Marnix G Witte

Int J Radiat Oncol Biol Phys· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival.
Wilma D Heemsbergen, Abrahim Al-Mamgani, Annerie Slot, Michel F H Dielwart, Joos V Lebesque

Radiother Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
Alize E H Scheenstra, Maddalena M G Rossi, José S A Belderbos, Eugène M F Damen, Joos V Lebesque

Int J Radiat Oncol Biol Phys· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local dose-effect relations for lung perfusion post stereotactic body radiotherapy.
Alize E H Scheenstra, Maddalena M G Rossi, José S A Belderbos, Eugène M F Damen, Joos V Lebesque

Radiother Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: results from a randomized trial.
Wilma D Heemsbergen, Abrahim Al-Mamgani, Marnix G Witte, Marcel van Herk, Joos V Lebesque

Radiother Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols.
Fan Liu, Ellen D Yorke, José S A Belderbos, Gerben R Borst, Kenneth E Rosenzweig, Joos V Lebesque

Int J Radiat Oncol Biol Phys· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer.
Jasper Nijkamp, Maddalena Rossi, Joos Lebesque, Jose Belderbos, Michel van den Heuvel

Radiother Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
Gilles Defraene, Laura Van den Bergh, Abrahim Al-Mamgani, Karin Haustermans, Wilma Heemsbergen, Joos V Lebesque

Int J Radiat Oncol Biol Phys· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design.
Monique H P Smitsmans, Josien de Bois, Jan-Jakob Sonke, Charles N Catton, David A Jaffray, Joos V Lebesque

Int J Radiat Oncol Biol Phys· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics.
Wilma D Heemsbergen, Abrahim Al-Mamgani, Marnix G Witte, Marcel van Herk, Floris J Pos, Joos V Lebesque

Int J Radiat Oncol Biol Phys· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
Gerben R Borst, Masayori Ishikawa, Jasper Nijkamp, Michael Hauptmann, Hiroki Shirato, Joos V Lebesque

Int J Radiat Oncol Biol Phys· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial.
Abrahim Al-Mamgani, Wilma D Heemsbergen, Peter C Levendag, Joos V Lebesque

Radiother Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relating dose outside the prostate with freedom from failure in the Dutch trial 68 Gy vs. 78 Gy.
Marnix G Witte, Wilma D Heemsbergen, Román Bohoslavsky, Floris J Pos, Abrahim Al-Mamgani, Joos V Lebesque

Int J Radiat Oncol Biol Phys· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature.
Abrahim Al-Mamgani, Joos V Lebesque, Wilma D Heemsbergen, Lisa Tans, Wim J Kirkels

Prostate· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?
Gerben R Borst, Jan-Jakob Sonke, Jose S Belderbos, Joos V Lebesque

Radiother Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dose-volume effects in the lung.
Lawrence B Marks, Soren M Bentzen, Joseph O Deasy, Feng-Ming Spring Kong, Jeffrey D Bradley, Joos V Lebesque

Int J Radiat Oncol Biol Phys· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
Erik-Jan Rijkhorst, Annemarie Lakeman, Jasper Nijkamp, Josien de Bois, Marcel van Herk, Joos V Lebesque

Int J Radiat Oncol Biol Phys· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.
Gerben R Borst, Jose Belderbos, Sjaak Burgers, Jan-Jakob Sonke, Joos Lebesque

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy.
Gerben R Borst, Masayori Ishikawa, Jasper Nijkamp, Michael Hauptmann, Hiroki Shirato, Joos V Lebesque

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
Abrahim Al-Mamgani, Wilma D Heemsbergen, Stephanie T H Peeters, Joos V Lebesque

Int J Radiat Oncol Biol Phys· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients.
Monique H P Smitsmans, Floris J Pos, Josien de Bois, Wilma D Heemsbergen, Jan-Jakob Sonke, Joos V Lebesque

Int J Radiat Oncol Biol Phys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis